Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 May;27(5):451-6.
doi: 10.1002/da.20672.

Anxiety impairs depression remission in partial responders during extended treatment in late-life

Affiliations
Randomized Controlled Trial

Anxiety impairs depression remission in partial responders during extended treatment in late-life

Adam Greenlee et al. Depress Anxiety. 2010 May.

Abstract

Objectives: More than half of older adults with major depressive disorder require extended treatment because of incomplete response during acute treatment. This study characterizes the effect of anxiety on remission during extended treatment for partial responders.

Methods: Following 6 weeks of escitalopram 10 mg/day+depression care management (DCM), 124 partial responders (Hamilton Rating Scale for Depression (HRSD) scores of 11-14) were randomly assigned to receive extended treatment with escitalopram 20 mg/day+DCM with or without interpersonal psychotherapy (IPT) for 16 weekly sessions. Remission was defined as three consecutive weekly scores <or=7 on the HRSD. We assessed concurrent symptoms of anxiety using the Hamilton Rating Scale for Anxiety at pretreatment and after 6 weeks. We conducted Cox regression analysis of time to remission and logistic modeling of rates of remission. We also explored whether anxiety severity altered any impact of IPT.

Results: Pretreatment anxiety was not associated with time to or rates of remission during 16 weeks of extended treatment. In contrast, more severe psychological symptoms of anxiety after 6 weeks of treatment was associated with both longer time to and lower rates of remission. However, there was no evidence that IPT showed any differential effects as a function of anxiety.

Conclusions: In partial responders to 6 weeks of lower-dose escitalopram and DCM, planning for extended treatment should account for psychological symptoms of anxiety.

PubMed Disclaimer

References

    1. Little JT, Reynolds CF, 3rd, Dew MA, et al. How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? American Journal of Psychiatry. 1998;155(8):1035–1038. - PubMed
    1. Thomas L, Mulsant BH, Solano FX, et al. Response speed and rate of remission in primary and specialty care of elderly patients with depression. American Journal of Geriatric Psychiatry. 2002;10(5):583–591. - PubMed
    1. Andreescu C, Lenze E, Dew M, et al. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. British Journal of Psychiatry. 2007;190(4):344–349. - PubMed
    1. Dew MA, Reynolds CF, 3rd, Houck PR, et al. Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Archives of General Psychiatry. 1997;54(11):1016–1024. - PubMed
    1. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. American Journal of Psychiatry. 1991;148(11):1512–1517. - PubMed

Publication types

MeSH terms